B6;D2-Tg(Myh6-ADCY8)7Hj/Orl

Status

Available to order

EMMA IDEM:02266
Citation informationRRID:IMSR_EM:02266 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6;D2-Tg(Myh6-ADCY8)7Hj/Orl
Alternative nameHAC8
Strain typeTransgenic Strains
Allele/Transgene symbolTg(Myh6-ADCY8)7Hj
Gene/Transgene symbolTg(Myh6-ADCY8)7Hj

Information from provider

ProviderNicole Defer
Provider affiliationINSERM U841
Genetic informationFragment 1956 to 5850 of the human ADCY8 (AC8) cDNA (GeneBank Ac. number:Z35309) was inserted in the Kpn1-EcoRV polylinker restriction site of pGEM(a-MHC) K7 giving the pGEM9z(-)/pGEM-a-MHC-AC8-SV40 recombinant plasmid. Before injection in male pronucleus of one-cell embryo, plasmid was digested with NotI/NsiI and AC8 cDNA purified.
Phenotypic informationNo apparent phenotype. On basal conditions cardiac function was normal. On release of parasympathetic tone, the intrinsic contractility is heightened and unresponsive to further beta-adrenergic stimulation. Upon aging homozygous animals present higher amount of cardiac fibrosis than wild-type and heterozygous mice.
Breeding historyFounders were obtained on 02/1998 and backcrossed with C57BL/6 mice. 3 generations of backcrosses were performed before mating brothers x sisters for homozygotes. Homozygous mice were obtained in 06/2000. All the mice derive from one couple (15 generations). They are currently bred as homozygotes. Homozygous mice are fertile and present no phenotype in basal conditions.
References
  • Enhanced cardiac function in transgenic mice expressing a Ca(2+)-stimulated adenylyl cyclase.;Lipskaia L, Defer N, Esposito G, Hajar I, Garel M C, Rockman H A, Hanoune J, ;2000;Circulation research;86;795-801; 10764414
  • Augmentation of cardiac contractility with no change in L-type Ca2+ current in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8).;Georget Marie, Mateo Philippe, Vandecasteele Grégoire, Jurevicius Jonas, Lipskaia Larissa, Defer Nicole, Hanoune Jacques, Hoerter Jacqueline, Fischmeister Rodolphe, ;2002;FASEB journal : official publication of the Federation of American Societies for Experimental Biology;16;1636-8; 12206999
  • Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8).;Georget Marie, Mateo Philippe, Vandecasteele Grégoire, Lipskaia Larissa, Defer Nicole, Hanoune Jacques, Hoerter Jacqueline, Lugnier Claire, Fischmeister Rodolphe, ;2003;FASEB journal : official publication of the Federation of American Societies for Experimental Biology;17;1380-91; 12890691

Information from EMMA

Archiving centreCNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France

Literature references

  • Enhanced cardiac function in transgenic mice expressing a Ca(2+)-stimulated adenylyl cyclase.;Lipskaia L, Defer N, Esposito G, Hajar I, Garel M C, Rockman H A, Hanoune J, ;2000;Circulation research;86;795-801; 10764414
  • Augmentation of cardiac contractility with no change in L-type Ca2+ current in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8).;Georget Marie, Mateo Philippe, Vandecasteele Grégoire, Jurevicius Jonas, Lipskaia Larissa, Defer Nicole, Hanoune Jacques, Hoerter Jacqueline, Fischmeister Rodolphe, ;2002;FASEB journal : official publication of the Federation of American Societies for Experimental Biology;16;1636-8; 12206999
  • Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8).;Georget Marie, Mateo Philippe, Vandecasteele Grégoire, Lipskaia Larissa, Defer Nicole, Hanoune Jacques, Hoerter Jacqueline, Lugnier Claire, Fischmeister Rodolphe, ;2003;FASEB journal : official publication of the Federation of American Societies for Experimental Biology;17;1380-91; 12890691

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).